Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
2019-11-28 10:37

New presentation from Stora Aktiedagen Stockholm on 25 Nov

CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Stockholm on 25 November. Would you like to read more about the programme and how to sign up, see attached notification.

 

2026-04-24 08:30
Qlife Holding AB publishes Annual Report for 2025
2026-04-23 15:21
Notice of the 2026 Annual General Meeting of Qlife Holding AB
2026-04-23 15:17
The ISP leaves notifications under the FDI Act without action in connection with allotment to certain investors in Qlife's rights issue
2026-04-01 18:33
Qlife announces the last day of trading in BTA
2026-03-24 08:30
Qlife announces the outcome of the rights issue and resolves on a directed issue of shares to guarantors
2026-03-17 09:00
Qlife provides business update on clinical progress, partnerships and commercialization initiatives
2026-03-17 08:45
The subscription period in Qlife’s rights issue ends on Thursday, 19 March 2026
2026-03-13 08:30
Hipro to accelerate Egoo development and regulatory approval in China following strong interest
2026-03-05 08:50
The subscription period in Qlife’s rights issue begins today

Qlife

Qlife Holding AB
Ullevigatan 19
411 40 Göteborg
info@egoo.health
Last published: 2025-02-10

Links

  • About
  • Investors
  • Egoo.health

Qlife is born to challenge the status quo in healthcare. We work to shift the perspective and turn today's view on health-care into tomorrow's focus on health-empowerment. We are on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. it's how we contribute to improving quality of life for every individual and for the greater society.